From the USA: Mortality Down for Rectal Cancer Surgery at NAPRC-Accredited Hospitals

National Accreditation Program for Rectal Cancer (NAPRC)-accredited hospitals have lower risk-adjusted mortality and morbidity for patients undergoing major rectal cancer surgery, according to a study published online March 28 in the Journal of the American College of Surgeons.

Calista M. Harbaugh, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a retrospective, observational study of Medicare beneficiaries aged 65 to 99 years with rectal cancer who underwent proctectomy from 2017 to 2020. The primary exposure was NAPRC accreditation; primary outcomes included mortality and 30-day complications, readmissions, and reoperations.

Source: Advances and More licensed by HealthDay